Superior Control of Bleeding Wounds for Percutaneous Procedures

SyvekNT contains poly-N-acetyl glucosamine (pGlcNAc) fibers, a polysaccharide polymer which activates plasma clotting proteins and platelets as well as induces vasoconstriction.1 SyvekNT has proven to be effective for controlling bleeding in patients undergoing hemodialysis, and for management of bleeding wounds such as vascular access sites, percutaneous catheters or tubes and surgical debridement.

Applicable for All Cardiac Catheterization Procedures

In a published U.S. clinical evaluation of SyvekNT for 1,000 consecutive patients2:

  • Included stenting, PTCA, electrophysiology and diagnostic catheterization procedures
  • Catheter sheaths ranged from 4-12 French
  • 76% of interventional patients sheaths were pulled with ACTs > 200
  • < 1.5% minor complications

Can Safely Reduce Time to Ambulation

Clinical Evidence: In a U.S. study of 200 patients undergoing a diagnostic coronary angiography using 6Fr catheters1:

  • 98% were able to safely ambulate
    after one hour of bedrest
  • No major adverse events and only
    2% minor adverse events*
  • Shortened bedrest may improve
    patient satisfaction
  • May improve catheterization
    laboratory efficiency

Easy to Use and Apply

SyvekNT is a soft, white, sterile non-woven pad of poly-N-acetyl glucosamine fibers isolated from microalgae. The 3 cm x 3 cm dressing is attached to medical-grade foam backing and stored in sterile, single-use package.

    Instructions for Use
  • Open SyvekNT and deliver it to the sterile field
  • Hold occlusive pressure proximal to the puncture site and remove the sheath
  • Allow 1-2 drops of blood from site
  • Immediately place SyvekNT over the puncture site and hold firm pressure, while continuing to hold proximal pressure
  • Slowly decrease amount of proximal pressure after 4 to 6 minutes (3 – 4 minutes for diagnostic procedures) while continuing to apply firm compression over the puncture site
  • Hold firm pressure on the puncture site until bleeding is controlled, then slowly release
  • Assess the site without disturbing SyvekNT, then cover with a transparent dressing

    Removing SyvekNT
  • Soak SyvekNT with water
  • Gently peel off SyvekNT

Contact us to schedule an
evaluation of SyvekNT.


Indications for Use: SyvekNT is intended for the promotion of rapid control of bleeding in patients following hemodialysis and in patients on anticoagulation therapy. SyvekNT is intended for use in the local management of bleeding wounds such as vascular access site, percutaneous catheters or tubes and surgical debridement.

Safety Information:
PRECAUTIONS: There are no known contraindications to the use of SyvekNT. Longer compression may be necessary for hypertensive or obese patients.
LATEX FREE
CAUTION: Federal (USA) law restricts this device to sale by or on the order of a physician or other licensed practitioner

Manufactured by Marine Polymer Technologies, Inc., Danvers, MA 01923. For instructions for use or additional product information, please contact us.

1. Palmer B, Gantt D, Lawrence M, et al. Am J Cardiol. 2004; 93:96-97
2. Nader R, Garcia J, Drushal K, et al. J Invas Cardiol. 2002; 14:305-307

*All of the minor adverse events were managed successfully with additional bedrest of 1 - 2 hours.1